iTeos Therapeutics (ITOS) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free ITOS Stock Alerts $10.57 -0.42 (-3.82%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media iTeos Therapeutics Short Interest DataCurrent Short Volume2,050,000 sharesPrevious Short Volume2,010,000 sharesChange Vs. Previous Month+1.99%Dollar Volume Sold Short$27.96 millionShort Interest Ratio / Days to Cover7.2Last Record DateMarch 31, 2024Outstanding Shares35,840,000 sharesFloat Size28,530,000 sharesShort Percent of Float7.19%Today's Trading Volume148,466 sharesAverage Trading Volume303,604 sharesToday's Volume Vs. Average49% Short Selling iTeos Therapeutics ? Sign up to receive the latest short interest report for iTeos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatITOS Short Interest Over TimeITOS Days to Cover Over TimeITOS Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now iTeos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,050,000 shares $27.96 million +2.0%7.2%7.2 $13.64 3/15/20242,010,000 shares $21.73 million +11.7%7.1%7.8 $10.81 2/29/20241,800,000 shares $19.28 million +5.9%6.3%6 $10.71 2/15/20241,700,000 shares $17.12 million -1.7%6.0%5.5 $10.07 1/31/20241,730,000 shares $17.21 million +16.1%6.1%5.7 $9.95 1/15/20241,490,000 shares $16.88 million -6.9%5.2%4.5 $11.33 Get the Latest News and Ratings for ITOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,600,000 shares $17.52 million -21.2%5.6%3.4 $10.95 12/15/20232,030,000 shares $22.03 million +17.3%7.1%4.3 $10.85 11/30/20231,730,000 shares $16.19 million +8.8%6.1%4 $9.36 11/15/20231,590,000 shares $16.01 million -9.1%5.6%3.7 $10.07 10/31/20231,750,000 shares $17.61 million -24.6%6.0%3.1 $10.06 10/15/20232,320,000 shares $20.97 million +28.2%7.9%4.3 $9.04 9/30/20231,810,000 shares $19.82 million +7.7%6.2%4.7 $10.95 9/15/20231,680,000 shares $20.70 million +3.7%5.7%4.4 $12.32 8/31/20231,620,000 shares $19.55 million +5.9%5.5%3.8 $12.07 8/15/20231,530,000 shares $18.21 million +8.5%5.3%3.5 $11.90 7/31/20231,410,000 shares $19.82 million -0.7%4.9%5.1 $14.06 7/15/20231,420,000 shares $19.51 million -6.0%4.9%5 $13.74 6/30/20231,510,000 shares $19.99 million -14.2%5.2%5.1 $13.24 6/15/20231,760,000 shares $24.99 million -7.4%6.1%6.1 $14.20 5/31/20231,900,000 shares $30.93 million +6.7%6.6%7.1 $16.28 5/15/20231,780,000 shares $26.52 million +6.6%6.1%7.3 $14.90 4/30/20231,670,000 shares $22.95 million -2.9%5.8%6.9 $13.74 4/15/20231,720,000 shares $23.50 million +1.8%5.9%6.8 $13.66 3/31/20231,690,000 shares $23.00 million +11.2%5.8%6.1 $13.61 3/15/20231,520,000 shares $23.91 million +2.0%5.3%5.2 $15.73 2/28/20231,490,000 shares $26.39 million +0.7%5.2%4.7 $17.71 2/15/20231,480,000 shares $27.44 million +0.7%5.1%4.6 $18.54 1/31/20231,470,000 shares $30.72 million +0.7%5.1%4.4 $20.90 1/15/20231,460,000 shares $27.84 million +5.0%5.1%4.4 $19.07 12/30/20221,390,000 shares $27.15 million -22.8%4.8%4.3 $19.53 12/15/20221,800,000 shares $38.65 million +9.8%6.2%5.9 $21.47 11/30/20221,640,000 shares $33.05 million -12.3%5.7%5.4 $20.15 11/15/20221,870,000 shares $38.67 million -7.4%6.5%6.1 $20.68 10/31/20222,020,000 shares $39.35 million +3.1%7.0%6.3 $19.48 10/15/20221,960,000 shares $35.32 million -27.4%6.8%5.9 $18.02 9/30/20222,700,000 shares $51.44 million +0.4%9.4%7.5 $19.05 9/15/20222,690,000 shares $54.61 million -0.4%9.3%7.1 $20.30 8/31/20222,700,000 shares $59.89 million -5.6%9.4%6.8 $22.18 8/15/20222,860,000 shares $72.64 million -1.7%9.9%6.8 $25.40Just Released: Insider's Secret to Trading Options (Ad)This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.Yes! Show Me This Strategy ITOS Short Interest - Frequently Asked Questions What is iTeos Therapeutics' current short interest? Short interest is the volume of iTeos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 2,050,000 shares of ITOS short. 7.19% of iTeos Therapeutics' shares are currently sold short. Learn More on iTeos Therapeutics' current short interest. What is a good short interest ratio for iTeos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ITOS shares currently have a short interest ratio of 7.0. Learn More on iTeos Therapeutics's short interest ratio. Which institutional investors are shorting iTeos Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of iTeos Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for iTeos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.19% of iTeos Therapeutics' floating shares are currently sold short. Is iTeos Therapeutics' short interest increasing or decreasing? iTeos Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,050,000 shares, an increase of 2.0% from the previous total of 2,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is iTeos Therapeutics' float size? iTeos Therapeutics currently has issued a total of 35,840,000 shares. Some of iTeos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. iTeos Therapeutics currently has a public float of 28,530,000 shares. How does iTeos Therapeutics' short interest compare to its competitors? 7.19% of iTeos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to iTeos Therapeutics: Replimune Group, Inc. (17.40%), Lexeo Therapeutics, Inc. (4.88%), Tourmaline Bio, Inc. (9.57%), Adaptive Biotechnologies Co. (6.57%), Voyager Therapeutics, Inc. (6.13%), Caribou Biosciences, Inc. (12.85%), Aura Biosciences, Inc. (6.17%), Tenaya Therapeutics, Inc. (4.99%), TScan Therapeutics, Inc. (0.60%), Solid Biosciences Inc. (3.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short iTeos Therapeutics stock? Short selling ITOS is an investing strategy that aims to generate trading profit from iTeos Therapeutics as its price is falling. ITOS shares are trading down $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against iTeos Therapeutics? A short squeeze for iTeos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ITOS, which in turn drives the price of the stock up even further. How often is iTeos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ITOS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Replimune Group Short Interest Data Lexeo Therapeutics Short Interest Data Tourmaline Bio Short Interest Data Adaptive Biotechnologies Short Interest Data Voyager Therapeutics Short Interest Data Caribou Biosciences Short Interest Data Aura Biosciences Short Interest Data Tenaya Therapeutics Short Interest Data TScan Therapeutics Short Interest Data Solid Biosciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ITOS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith